The Health Quarters: Strengthening cGMP Compliance for Pharmaceutical Drugs and Biologics Manufacturing | 4th Issue, March 2022
The fourth (4th) issue release ofThe Health Quarters (HQ)newsletter focuses and touches on a wide range of technologies and solutions for the manufacture of pharmaceutical drugs and biological products.
With the aim to strengthen the core of cGMP compliance in our clients' manufacturing process,The HQsheds light on Esco Aster joining the World Vaccine Congress for the 6thtime on Apr.18-21 at Marriott Marquis Washington DC, USA.Also, learn about our cGMP Cleanroom Solutions for COVID- Repurposed Drugs (RDs), Monoclonal Antibodies (mAbs), Vaccines, and Oral Solid Dosage (OSD) Antiviral Drugs as well as theex-Cell-entfeatures of the Cell Processing Isolator, containing guides in choosing the right isolator for your cell therapy process.
Get a free copy of The HQ's newsletter and ensure cGMP compliance for your facilities!